ENTPD1 and COVID-19: Similar to the analysis of CD39+ Tregs populations, we did not find significant changes in the relative content of CD73+ regulatory T lymphocytes and subsets in both groups of patients with acute COVID-19 and compared to the healthy donors group (Figure 4(1)).